  Molecular imaging refers to a class of noninvasive biomedical imaging
techniques with the sensitivity and specificity to image biochemical variations
in-vivo. An ideal molecular imaging technique visualizes a biochemical target
according to a range of criteria, including high spatial and temporal
resolution, high contrast relative to non-targeted tissues, depth-independent
penetration into tissue, lack of harm to the organism under study, and low
cost. Because no existing molecular imaging modality is ideal for all purposes,
new imaging approaches are needed. Here we demonstrate a novel molecular
imaging approach, called nanodiamond imaging, that uses nanodiamonds containing
nitrogen-vacancy (NV) color centers as an imaging agent, and image nanodiamond
targets in pieces of chicken breast. Nanodiamonds can be tagged with
biologically active molecules so they bind to specific receptors; their
distribution can then be quantified in-vivo via optically-detected magnetic
resonance of the NVs. In effect, we are demonstrating Optically-Detected
Functional-Electron-Spin-Resonance-Imaging, OD-f-ESRI. By combining optical
detection with magnetic resonance, nanodiamond imaging achieves high
sensitivity and high spatial resolution. It is absent of the complications of
ionizing radiation, and the cost should be similar to all-optical imaging.
Because nanodiamond imaging is limited by the depth of optical penetration into
tissue to depths of a few cm, nanodiamond imaging should open up new avenues of
investigation for applications where high depth penetration is not required,
such as in small-animal imaging, tumor margin imaging, sentinel lymph node
mapping, and perhaps mammography.
